Influence of perinatal inflammation on the neurodevelopmental outcome of premature infants.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 31 10 2017
medline: 12 4 2019
entrez: 31 10 2017
Statut: ppublish

Résumé

To evaluate the influence of perinatal inflammation on neurodevelopmental outcome of premature infants. From a retrospective cohort study of women with preterm labor with intact membranes or preterm prelabor rupture of membranes (PPROM) with an amniocentesis to rule out intra-amniotic inflammation (IAI) and microbial invasion of the amniotic cavity (MIAC), we evaluated neurodevelopmental outcome of their infants born between 24.0 and 34.0 weeks gestation. Women with clinical chorioamnionitis at admission were excluded. Neurodevelopmental outcome was screened with the Ages & Stages Questionnaire (ASQ)-3. We analyzed the relationship between an altered ASQ-3 and antenatal, intra-partum and post-partum factors related to perinatal inflammation. Among 98 infants evaluated, 22% had an abnormal score. Amniotic fluid interleukin-6 levels and early-onset sepsis (EOS) were independent factors of an altered ASQ-3 with delivery <26.0 weeks being the strongest predictor. In premature infants, the presence of IAI, delivery <26.0 weeks and EOS were found to be independent factors of an altered ASQ-3.

Identifiants

pubmed: 29082789
doi: 10.1080/14767058.2017.1399118
doi:

Substances chimiques

Interleukin-6 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1069-1077

Auteurs

Adriano Rodríguez-Trujillo (A)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.

José Ríos (J)

b Biostatistics and Data Management Core Facility , IDIBAPS, Hospital Clinic , Barcelona , Spain.
c Biostatistics Unit, Faculty of Medicine , Universitat Autónoma de Barcelona , Barcelona , Spain.

Martina A Ángeles (MA)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.

David E Posadas (DE)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.

Clara Murillo (C)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.

Claudia Rueda (C)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.

Francesc Botet (F)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.

Jordi Bosch (J)

d Microbiology, Biomedical Diagnostic Center , Hospital Clínic and ISGlobal (Barcelona Institute for Global Health), University of Barcelona , Barcelona , Spain.

Andrea Vergara (A)

d Microbiology, Biomedical Diagnostic Center , Hospital Clínic and ISGlobal (Barcelona Institute for Global Health), University of Barcelona , Barcelona , Spain.

Eduard Gratacós (E)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.
e Centre for Biomedical Research on Rare Diseases (CIBER-ER) , Barcelona , Spain.

Montse Palacio (M)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.
e Centre for Biomedical Research on Rare Diseases (CIBER-ER) , Barcelona , Spain.

Teresa Cobo (T)

a BCNatal - Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), Fetal i + D Fetal Medicine Research Center, IDIBAPS, University of Barcelona , Barcelona , Spain.
e Centre for Biomedical Research on Rare Diseases (CIBER-ER) , Barcelona , Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH